Fedele Debora, Bicchiega Virginia, Collo Alessandro, Barutta Federica, Pistone Erika, Gruden Gabriella, Bruno Graziella
Department of Medical Sciences, University of Turin, Turin, Italy.
Italian Auxologic Institute, Verbania, Italy.
PLoS One. 2017 Jul 13;12(7):e0181212. doi: 10.1371/journal.pone.0181212. eCollection 2017.
Natriuretic peptides are not only involved in cardiovascular adaption to various conditions, but also in metabolic diseases. We performed this study to assess the effect of a very short time of lifestyle inpatient intervention on NTproBNP values in normotensive subjects with severe obesity and normal cardiac function.
We recruited 14 consecutive obese normotensive subjects with normal cardiac function who were aged 30 years and more and were referred to inpatient rehabilitation in an academic clinic over a two months period. They were examined at baseline and after a 3-weeks program including dietary intervention with hypocaloric diet and assisted personalized physical aerobic and anaerobic activities and compared to age, sex and BMI-matched control subjects under usual care.
BMI significantly decreased (40.8 ±1.6 vs 42.3 ± 1.6 kg/m2, p <0.0001). Median reduction in body weight was 4.9 kg (interquartile range 2.4-5.2 kg). After diet and exercise-induced weight loss, plasma NTproBNP levels showed an almost two-fold increase, which was statistically significant (28.2 ± 12.3 vs 17.2 ± 13.2 ng/L, p = 0.01), and particularly relevant in the subgroup with NT-proBNP values below median values compared to those with higher values (p = 0.02). No significant variations were found in control subjects (18.0 ± 13.0 vs 16.5 ± 11.2 ng/L, p = 0.18). The lipid profile was significantly ameliorated, and both HbA1c and insulin levels showed a marginally non-significant decrease after treatment.
An almost two-fold increase in NTproBNP levels was evident after a very short time period of lifestyle intervention in normotensive severe obese patients without cardiac disease. This finding might have clinical relevance, considering the role of NT-proBNP as risk factor of impaired glucose tolerance.
利钠肽不仅参与心血管系统对各种情况的适应,还与代谢性疾病有关。我们开展本研究以评估极短时间的住院生活方式干预对严重肥胖且心功能正常的血压正常受试者的NTproBNP值的影响。
我们连续招募了14名年龄30岁及以上、心功能正常的肥胖血压正常受试者,他们在两个月内被转至一家学术诊所接受住院康复治疗。在基线时以及在一个为期3周的项目结束后对他们进行检查,该项目包括低热量饮食的饮食干预以及个性化的有氧和无氧辅助体育活动,并将他们与接受常规护理的年龄、性别和BMI匹配的对照受试者进行比较。
BMI显著降低(40.8±1.6 vs 42.3±1.6kg/m²,p<0.0001)。体重中位数下降了4.9kg(四分位间距2.4 - 5.2kg)。经过饮食和运动诱导的体重减轻后,血浆NTproBNP水平几乎增加了两倍,具有统计学意义(28.2±12.3 vs 17.2±13.2ng/L,p = 0.01),与NT-proBNP值高于中位数的亚组相比,在NT-proBNP值低于中位数的亚组中尤为显著(p = 0.02)。对照受试者未发现显著变化(18.0±13.0 vs 16.5±11.2ng/L,p = 0.18)。血脂谱显著改善,治疗后糖化血红蛋白和胰岛素水平均有轻微的非显著下降。
在没有心脏病的血压正常的严重肥胖患者中,经过极短时间的生活方式干预后,NTproBNP水平明显增加了近两倍。考虑到NT-proBNP作为糖耐量受损风险因素的作用,这一发现可能具有临床意义。